Daiwa Securities Group
ACET icon

Daiwa Securities Group’s Adicet Bio ACET Stock Holding History

Daiwa Securities Group’s Portfolio ACET Stock Details ACET Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-7
Closed – – 1319
2023
Q3 		$0 Hold
7
– – ﹤0.01% 1287
2023
Q2 		$0 Hold
7
– – ﹤0.01% 1317
2023
Q1 		$1K Hold
7
– – ﹤0.01% 1236
2022
Q4 		$1K Hold
7
– – ﹤0.01% 1253
2022
Q3 		$2K Hold
7
– – ﹤0.01% 1214
2022
Q2 		$2K Hold
7
– – ﹤0.01% 1217
2022
Q1 		$2K Buy
7
+3
+75% +$690 ﹤0.01% 1236
2021
Q4 		$1K Hold
4
– – ﹤0.01% 1320
2021
Q3 		$0 Hold
4
– – ﹤0.01% 1309
2021
Q2 		$1K Hold
4
– – ﹤0.01% 1172
2021
Q1 		$1K Buy
4
+2
+100% +$459 ﹤0.01% 1178
2020
Q4 		$0 Hold
2
– – ﹤0.01% 1253
2020
Q3 		$0 Hold
2
– – ﹤0.01% 1178
2020
Q2 		$0 Hold
2
– – ﹤0.01% 1203
2020
Q1 		$0 Hold
2
– – ﹤0.01% 1208
2019
Q4 		$0 Hold
2
– – ﹤0.01% 1198
2019
Q3 		$2K Hold
2
– – ﹤0.01% 1118
2019
Q2 		$2K Hold
2
– – ﹤0.01% 1142
2019
Q1 		$1K Buy
+2
New +$1.82K ﹤0.01% 1155

Other funds holding ACET

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Daiwa Securities Group's ACET Position: Q4 2023 in Review

Daiwa Securities Group sold out of Adicet Bio (ACET) in Q4 2023, closing a stake of 7 shares.

Daiwa Securities Group first reported a position in ACET in Q1 2019 and held it in 19 quarters. The position peaked at $2K in Q3 2022. 76 funds tracked by Wall St. Rank hold ACET as of Q4 2023.

  • Daiwa Securities Group reported no remaining Adicet Bio position as of Q4 2023 after selling out during the quarter.
  • Daiwa Securities Group sold 7 Adicet Bio shares in Q4 2023.
  • Daiwa Securities Group first reported a position in Adicet Bio in Q1 2019 and held it in 19 quarters.
  • Daiwa Securities Group's Adicet Bio position peaked at $2K in Q3 2022.
  • 76 funds tracked by Wall St. Rank held Adicet Bio as of Q4 2023.

Based on Daiwa Securities Group's 13F filing for Q4 2023, filed 31 Jan 2024.